Phase 3 Study Sees Positive Top-line Results of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness
Jazz Pharmaceuticals plc announced positive top-line results from a global, double-blind, placebo-controlled, randomized-withdrawal, multicenter Phase 3 study evaluating the efficacy and safety of JZP-258 for the treatment of...
Read More